How to access hip replacement through public healthcare in 2027: An evidence-based pathway guide

How to access hip replacement through public healthcare in 2027 begins with a primary-care assessment and referral to a public orthopaedic service. The exact process differs between Ireland’s HSE system and NHS England, so patients should not treat waiting-time figures from one jurisdiction as evidence for the other. 5

Confirming the public healthcare pathway

In Ireland, public hip replacement usually starts with a GP referral to a consultant orthopaedic surgeon in a public hospital. The consultant-led service assesses the diagnosis, functional impairment and suitability for surgery before placing an eligible patient on a scheduled-care waiting list. The HSE describes orthopaedic care as part of hospital services, while public-hospital eligibility and charges are also outlined by Citizens Information. 5 11

In England, a GP and patient can agree that specialist assessment is required, after which the referral may be managed through the NHS e-Referral Service. The patient has a legal right to choose where the first outpatient appointment takes place, although selecting an alternative provider does not guarantee a shorter surgical wait or access to a particular technique. 3

Clinical assessment and eligibility

A hip replacement is generally considered when a condition such as severe osteoarthritis or other joint damage substantially limits daily function and symptoms have not responded adequately to conservative management. Conservative care can include physiotherapy, pain management and weight management, and musculoskeletal programmes are intended to support this stage before surgical referral. 4 9

The consultant determines whether surgery is clinically appropriate and assigns the patient to a priority level according to factors such as pain, mobility impairment and functional decline. The public pathway is therefore not simply a first-come, first-served queue. Clinical urgency, hospital capacity and reassessment of the patient’s condition can affect the timing of treatment. 10 5

How waiting lists are organised

Ireland’s public waiting lists are managed through the HSE scheduled-care system, with cases prioritised according to clinical urgency. The National Treatment Purchase Fund may support procedures in private hospitals for some patients already on public waiting lists, forming part of national efforts to reduce delays. Eligibility for such arrangements and the treatment provider are determined within the relevant public waiting-list process. 6

Waiting-list information should be interpreted cautiously because a national figure may combine different hospitals, specialties or stages of care. The Irish Waiting List Action Plan is designed to improve patient management and waiting-list performance, while Sláintecare describes broader changes involving regional health areas and integrated service delivery. Measures planned or developed for 2027 may alter referral and treatment pathways, but future performance cannot be assumed. 8 12

What NHS England figures show

For comparison, NHS England data reported for May 2026 showed a national median wait of 15 weeks for hip replacement within trauma and orthopaedics, with the 90th percentile at 40 weeks and approximately 105,000 completed pathways annually. Among 10 profiled trusts, median waits ranged from 10 weeks at University College London Hospitals to 19 weeks at the Royal Free London, while large-list English providers ranged from about six to 40 weeks. 1

Another analysis of NHS England data reported approximately 237,020 patients waiting, a median of about 15 weeks and a 92nd percentile of about 39 weeks. These figures are specialty or trust-level measures rather than a guaranteed interval from GP referral to the operation. They also relate to England, not the HSE in Ireland, and should not be used to predict an individual patient’s 2027 date. 4

Options when the public wait is prolonged

Patients in Ireland may ask the hospital or relevant public service how their waiting-list status is recorded, whether clinical circumstances have changed, and whether any national waiting-list initiative applies. The NTPF can purchase treatment in private hospitals for selected public patients, but this is not the same as arranging private treatment independently. Eligibility, clinical priority and administrative availability remain significant constraints. 6

European cross-border routes may also be relevant in specific circumstances. The HSE Cross Border Healthcare Directive and Treatment Abroad Scheme set out separate conditions for patients seeking care outside Ireland, including requirements concerning eligibility, authorisation and medically appropriate treatment. A patient should obtain information from the HSE or a qualified healthcare professional before relying on either route, because approval is not automatic. 7

Managing changes while waiting

Hip symptoms can change during a prolonged wait, so the referring GP and hospital should be informed about materially worsening pain, declining mobility or new functional limitations. The consultant-led team remains responsible for clinical priority decisions, and the patient’s position may need reassessment if the underlying condition or level of impairment changes. Patient Advocacy Service information can help explain rights and responsibilities in waiting-list management. 10

Complaints about communication, administration or delays can be raised through the relevant HSE complaints process, with the Ombudsman providing guidance about complaints involving HSE services. This route does not replace clinical review and does not guarantee an earlier operation. Public healthcare access also involves practical uncertainties, including hospital capacity, regional variation, referral administration and the possibility that conservative treatment remains appropriate for longer than expected. 13

Questions to resolve before referral

A patient preparing for a public referral should establish which condition is being assessed, whether imaging or other investigations are required, which hospital will receive the referral and how the waiting-list stage will be recorded. It is also important to ask how clinical priority is reviewed, whom to contact if mobility deteriorates and whether the service operates through a regional elective-care arrangement. These details provide a clearer account of the pathway than a headline national average. 5 8

For 2027, the most reliable approach is to separate confirmed current arrangements from policy intentions. Ireland’s HSE referral, scheduled-care, NTPF and cross-border information describes available mechanisms, while the Waiting List Action Plan and Sláintecare describe continuing system reform. NHS England statistics provide useful comparative context only. No source supplied establishes a single Ireland-wide 2027 waiting time for hip replacement, so an individual hospital and consultant assessment remain decisive. 6 7 8

Sources

1. PlainNHS, “Hip Replacement: NHS waiting times,” plainnhs.co.uk
2. HospitalWaits, “Hip and knee replacement waiting times,” hospitalwaits.co.uk
3. Orthopaedic Innovation, “How to Get Ahead of the NHS Waiting List for Hip Replacement Surgery,” orthopaedicinnovation.co.uk
4. TreatCompare, “Hip replacement surgery UK 2026,” treatcompare.com
5. Health Service Executive, Orthopaedics, hse.ie
6. National Treatment Purchase Fund, ntpf.ie
7. HSE Cross Border Healthcare Directive, hse.ie
8. Government of Ireland, Waiting List Action Plan and Sláintecare, gov.ie
9. HSE Clinical Design and Innovation, Musculoskeletal Programme, hse.ie
10. Patient Advocacy Service, patientadvocacyservice.ie
11. Citizens Information, Public Hospital Services, citizensinformation.ie
12. Health Pricing Office, hpo.ie
13. Office of the Ombudsman, HSE complaints guidance, ombudsman.ie